[HTML][HTML] Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey
AHE Küçükdiler, İ Yavaşoğlu, C Selim, CA Mutlu… - Leukemia Research …, 2021 - Elsevier
We retrospectively evaluated the use of gemtuzumab ozogamicin (GO) in relapsed refractory
(R/R) acute myeloid leukemia (AML) patients. Twenty-one CD33 positive R/R AML patients …
(R/R) acute myeloid leukemia (AML) patients. Twenty-one CD33 positive R/R AML patients …